Literature DB >> 17060593

Lesion pathology predicts response to plasma exchange in secondary progressive MS.

U K Zettl1, H P Hartung, A Pahnke, W Brueck, R Benecke, J Pahnke.   

Abstract

Mesh：

Year:  2006        PMID： 17060593     DOI： 10.1212/01.wnl.0000240067.03948.68

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

Review 1.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

2.  [Immunotherapy and infectious issues in multiple sclerosis. Self-injectable and oral drugs for immunotherapy].

Authors:  A Winkelmann; M Löbermann; E C Reisinger; H-P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 3.  B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.

Authors:  Silke Kinzel; Martin S Weber
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 4.  [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Authors:  H-P Hartung
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 5.  Multiple sclerosis treatment and infectious issues: update 2013.

Authors:  A Winkelmann; M Loebermann; E C Reisinger; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 6.  B cells: no longer the nondominant arm of multiple sclerosis.

Authors:  Eric C Klawiter; Anne H Cross
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 6.030

7.  B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.

Authors:  Heather L Wilson
Journal:  Biologics       Date:  2012-05-07

Review 8.  Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.

Authors:  Klaus Lehmann-Horn; Silke Kinzel; Martin S Weber
Journal:  Int J Mol Sci       Date:  2017-09-23       Impact factor: 5.923

9.  Aggressive multiple sclerosis (2): Treatment.

Authors:  Georgina Arrambide; Ellen Iacobaeus; Maria Pia Amato; Tobias Derfuss; Sandra Vukusic; Bernhard Hemmer; Lou Brundin; Mar Tintore
Journal:  Mult Scler       Date:  2020-06-12       Impact factor: 6.312

Review 10.  The Role of Antibodies in the Pathogenesis of Multiple Sclerosis.

Authors:  Xiaoli Yu; Michael Graner; Peter G E Kennedy; Yiting Liu
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.